fda semaglutide warning september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and Tirzepatide "kits" US FDA removes suicidal thoughts

Even mild dehydration thickens your blood, reduces plasma volume, and makes blood pressure regulation harder for your cardiovascular system

Collectively, these mechanisms explain how population-level genetic associations translate into molecular drivers of MASLD and its progression to T2DM ( Figure 4 )

The goal is to integrate PA into the normal prescription workflow, enabling real-time eligibility checks and reducing manual steps

Int J Mol Sci 24(2):1703

The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis

The present study is clinically significant as it demonstrates that the BP-lowering effect of SGLT2i is more effective in non-obese patients